GIANNINI, RICCARDO
 Distribuzione geografica
Continente #
NA - Nord America 5.286
AS - Asia 2.365
EU - Europa 2.325
SA - Sud America 281
Continente sconosciuto - Info sul continente non disponibili 165
AF - Africa 123
Totale 10.545
Nazione #
US - Stati Uniti d'America 5.136
SG - Singapore 754
CN - Cina 673
DE - Germania 600
IT - Italia 467
SE - Svezia 388
HK - Hong Kong 339
GB - Regno Unito 241
BR - Brasile 231
VN - Vietnam 206
BG - Bulgaria 149
CA - Canada 107
TR - Turchia 102
FR - Francia 93
RU - Federazione Russa 83
FI - Finlandia 74
IN - India 63
AT - Austria 59
CI - Costa d'Avorio 50
JP - Giappone 48
RO - Romania 39
UA - Ucraina 36
SN - Senegal 28
KR - Corea 26
BE - Belgio 23
IQ - Iraq 21
MX - Messico 21
PK - Pakistan 19
AR - Argentina 17
BD - Bangladesh 16
NL - Olanda 15
SA - Arabia Saudita 14
NG - Nigeria 12
ZA - Sudafrica 12
CH - Svizzera 11
UZ - Uzbekistan 11
ES - Italia 10
ID - Indonesia 10
PL - Polonia 10
EC - Ecuador 9
IR - Iran 8
VE - Venezuela 8
CO - Colombia 7
JM - Giamaica 7
MA - Marocco 7
IL - Israele 6
JO - Giordania 6
NP - Nepal 6
EU - Europa 5
IE - Irlanda 5
MY - Malesia 5
EG - Egitto 4
ET - Etiopia 4
PH - Filippine 4
DZ - Algeria 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LT - Lituania 3
PA - Panama 3
PE - Perù 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
AL - Albania 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
EE - Estonia 2
GE - Georgia 2
HN - Honduras 2
HR - Croazia 2
HU - Ungheria 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
NI - Nicaragua 2
PT - Portogallo 2
PY - Paraguay 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
CG - Congo 1
CL - Cile 1
CR - Costa Rica 1
DK - Danimarca 1
DM - Dominica 1
GY - Guiana 1
MD - Moldavia 1
MN - Mongolia 1
MS - Montserrat 1
MT - Malta 1
MV - Maldive 1
NA - Namibia 1
OM - Oman 1
PR - Porto Rico 1
PS - Palestinian Territory 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 10.382
Città #
Ashburn 535
Singapore 412
Dallas 380
Fairfield 380
Woodbridge 378
Chandler 371
Hong Kong 331
Santa Clara 298
Houston 262
Ann Arbor 240
San Jose 240
Seattle 177
Cambridge 149
Beijing 148
Sofia 146
Wilmington 133
New York 130
Shanghai 129
Los Angeles 86
London 80
Ottawa 76
Boardman 75
Council Bluffs 69
Princeton 69
Serra 63
Pisa 60
Lawrence 58
Lauterbourg 56
Medford 51
Abidjan 50
Des Moines 49
Ho Chi Minh City 45
Milan 45
Vienna 45
Izmir 43
Florence 39
Hanoi 39
Jacksonville 39
Munich 39
Tokyo 39
Istanbul 38
Frankfurt am Main 36
Nanjing 36
Dearborn 33
Bremen 32
Columbus 30
Hefei 29
Dakar 28
Seoul 26
Buffalo 24
Brussels 22
Nürnberg 22
Redondo Beach 22
São Paulo 22
Boulder 19
Cascina 19
Falls Church 19
Turku 19
Dong Ket 18
San Diego 18
The Dalles 18
Chicago 17
Orem 16
Ogden 15
Düsseldorf 12
Kunming 11
Lagos 11
Nanchang 11
Bern 10
Changsha 10
Fuzhou 10
Montreal 10
Pune 10
Rome 10
Baghdad 9
Da Nang 9
Haiphong 9
Tashkent 9
Brasília 8
Hebei 8
Lancaster 8
Philadelphia 8
Phoenix 8
Ploieşti 8
Redmond 8
Rio de Janeiro 8
Stockholm 8
Tianjin 8
Washington 8
Atlanta 7
Bucharest 7
City of London 7
Helsinki 7
Jiaxing 7
Sacile 7
San Francisco 7
Shenyang 7
Toronto 7
Zhengzhou 7
Amman 6
Totale 6.937
Nome #
Antiproliferative and Proapoptotic Activity of Sunitinib on Endothelial and Anaplastic Thyroid Cancer Cells via Inhibition of Akt and ERK1/2 Phosphorylation and by Down-Regulation of Cyclin-D1. 268
Low-Risk Differentiated Thyroid Cancer with BRAFV600E mutation is more difficult to cure than negative cases: a 5-year follow-up study. 261
null 259
Identification of two distinct molecular subtypes by digital RNA counting of "non-invasive follicular tumour with papillary-like nuclear features (NIFTP)" 257
Malignant pleural mesothelioma and mesothelial hyperplasia: A new molecular tool for the differential diagnosis 250
Molecular testing in the diagnosis of differentiated thyroid carcinomas 228
Incidental versus clinically evident thyroid cancer: A 5-year follow-up study 222
EGFR and KRAS mutational analysis in a large series of Italian non-small cell lung cancer patients: 2,387 cases from a single center 216
210P: Digital gene expression profiling to separate malignant pleural mesothelioma from benign reactive mesothelial hyperplasia 215
Smooth Introduction of Semantic Tagging in Genotyping Procedures 213
BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: A 15-year median follow-up study 209
Cytological and Ultrasound Features of Thyroid Nodules Correlate with Histotypes and Variants of Thyroid Carcinoma 201
Aberrant expression of anaplastic lymphoma kinase in lung adenocarcinoma: Analysis of circulating free tumor RNA using one-step reverse transcription-polymerase chain reaction 198
Analysis of Fusion Genes by NanoString System: A Role in Lung Cytology? 195
Correlation between the BRAF V600E Mutation and Tumor Invasiveness in Papillary Thyroid Carcinomas Smaller than 20 Millimeters: Analysis of 1060 Cases 192
Adipose tissue in COVID-19: detection of SARS-CoV-2 in adipocytes and activation of the interferon-alpha response 191
Applications of tissue microarray technology in immunohistochemistry: a study on c-kit expression in small cell lung cancer 185
ALK rearrangement in a large series of consecutive non-small cell lung cancers: Comparison between a new immunohistochemical approach and fluorescence in situ hybridization for the screening of patients eligible for crizotinib treatment 184
Effect of Interferon-alpha and -beta on NIS, TPO and Thyroglobulin expression in primary human thyroid cell cultures 180
BRAFV600E mutation is an indipendent predictive prognostic factor for persistent/recurrent disease in low risk differentiated Thyroid cancer patients: a 5 year follow-up study. 177
Activation of Type I and Type II Interferon Signaling in SARS-CoV-2-Positive Thyroid Tissue of Patients Dying from COVID-19 173
Immune Profiling of Deficient Mismatch Repair Colorectal Cancer Tumor Microenvironment Reveals Different Levels of Immune System Activation 169
A six-gene panel to label follicular adenoma, low- and high-risk follicular thyroid carcinoma 168
Management of Genotyping-related Documents by Integrated Use of Semantic Tagging 166
Immune Profiling of Thyroid Carcinomas Suggests the Existence of Two Major Phenotypes: an ATC-like and a PDTC-like 161
null 159
Extensive clinical experience - Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma 159
COVID-19 autopsy cases: detection of virus in endocrine tissues 158
Association between DNA methylation profile and malignancy in follicular-patterned thyroid neoplasms 156
Histological pattern and gene expression profiling of thyroid tissue in subjects with obesity 153
null 150
Role of gene expression profiling in defining indeterminate thyroid nodules in addition to BRAF analysis 148
Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in Tall-Cell Variant of papillary thyroid carcinoma 142
Role of NRAS mutations as prognostic and predictive markers in metastatic colorectal cancer 142
Galectin-3 and oncofetal-fibronectin expression in thyroid neoplasia as assessed by reverse transcription-polymerase chain reaction and immunochemistry in cytologic and pathologic specimens 141
Thyroid papillary carcinoma: preliminary evidence for a germ-line single nucleotide polymorphism in the Fas gene 140
BRAF status of follicular variant of papillary thyroid carcinoma and its relationship to its clinical and cytological features. 137
Type I interferons modulate the expression of thyroid peroxidase, sodium/iodide symporter, and thyroglobulin genes in primary human thyrocyte cultures 136
Coexistence of TERT promoter and BRAF mutations in cutaneous melanoma is associated with more clinicopathological features of aggressiveness 135
Analysis of BRAF point mutation and RET/PTC rearrangement refines the fine-needle aspiration diagnosis of papillary thyroid carcinoma 134
Functional Characterization of the Novel T599I-VKSRdel BRAF Mutation in a Follicular Variant Papillary Thyroid Carcinoma 133
Osteopontin is overexpressed in human papillary thyroid carcinomas and enhances thyroid carcinoma cell invasiveness 133
Effect of Interferon-α and –ß on NIS, TPO and Thyroglobulin expression in primary human thyroid cell cultures 131
Mitogenic effects of the up-regulation of minichromosome maintenance proteins in anaplastic thyroid carcinoma 131
Short term follow-up outcome of stage I thyroid cancer patients is worst when BRAFV600E mutation is present in the primary tumor. 127
BRAFV600E mutation is an indipendent bad prognostic factor for the out come of patients with papillary thyroid carcinoma: a 15-year median follow-up study. 125
Significato prognostico della mutazione di BRAF in pazienti affetti da carcinoma papillare della tiroide con follow-up di 20 anni. 124
The BRAF(V600E) mutation is an independent, poor prognostic factor for the outcome of patients with low-risk intrathyroid papillary thyroid carcinoma: single-institution results from a large cohort study 124
The heterogeneous distribution of BRAF mutation supports the independent clonal origin of distinct tumor foci in multifocal papillary thyroid carcinoma 122
. Utilità della ricerca della mutazione di BRAF nel tumore primitivo di pazienti affetti da carcinoma papillare della tiroide a basso rischio. 118
ALK Rearrangement in a Large Series of Consecutive Non-Small Cell Lung Cancers: Comparison Between a New Immunohistochemical Approach and Fluorescent In Situ Hybridization for the Screening of Patients Eligible for Crizotinib Treatment. 116
Low elasticity of thyroid nodules at ultrasound elastography is correlated with malignancy, degree of fibrosis and high expression of galectin-3 and fibronectin-1 116
Establishment of a non-tumorigenic papillary thyroid cell line (FB-2) carrying the RET/PTC1 rearrangement 115
KIF5B/RET fusion gene analysis in a selected series of cytological specimens of EGFR, KRAS and EML4-ALK wild-type adenocarcinomas of the lung. 112
null 110
Identification of Two Distinct Molecular Subtypes of Non-Invasive Follicular Neoplasm with Papillary-Like Nuclear Features by Digital RNA Counting 101
null 98
Digital gene expression profiling of a series of cytologically indeterminate thyroid nodules 97
Association of BRAF V600E Mutation with Poor Clinicopathologic Outcomes in 500 Consecutive Cases of Papillary Thyroid Carcinoma 96
Incidental versus clinically evident thyroid cancer: A 5-year follow-up study. 86
null 84
Meningeal hemangiopericytoma metastatic to the adrenal gland with multiple metastases to bones and lungs: a case report Anno 2004 Titolo della Rivista Titolo TUMORI ISSN 0300-8916 80
Transcriptomic Profiling of the Tumor Microenvironment in High-Grade Serous Carcinoma: A Pilot Study of Morphologic and Molecular Distinctions Between Classic and SET Patterns 78
null 78
Teupolioside and Graminex (Xipag®) combined therapy induced anti-inflammatory effects and decreased dihydrotestosterone levels in the prostate tissue of patients with benign prostate hyperplasia: results of a pilot study 77
Papillary Thyroid Carcinoma and Body Mass Index: The Role of Immune System in Tumor Microenvironment 75
Differential clinicopathological risk and prognosis of major papillary thyroid cancer variants 72
Follicular-derived neoplasms: morphometric and genetic differences. 71
null 66
null 62
Wnt/B-catenin Activation and TP53 Mutations Associate With Distinct Immune Profiles in Advanced Thyroid Cancer 47
Molecular Differences in Invasive Encapsulated Follicular Variant of Papillary Thyroid Carcinoma (IEFVPTC) and Infiltrative Follicular Variant of Papillary Thyroid Carcinoma (IFVPTC): The Role of Extracellular Matrix 44
Obesity, hyperfiltration and early kidney damage: a new formula for the estimation of creatinine clearance 30
null 28
Presence of BRAF V600E in Very Early Stages of Papillary Thyroid Carcinoma 6
Outcomes of the Tall-Cell Variant of Papillary Thyroid Carcinoma in Patients with Different Ages: A 17-Year Mono-Institutional Experience 4
Totale 10.545
Categoria #
all - tutte 30.559
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.559


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022750 0 43 26 61 140 108 26 44 31 25 41 205
2022/20231.128 144 189 69 114 117 133 11 84 185 9 63 10
2023/2024514 43 44 49 32 68 120 21 9 14 26 24 64
2024/20252.151 24 77 20 124 227 227 139 96 237 256 233 491
2025/20262.560 149 318 330 174 253 221 401 109 165 245 94 101
2026/2027185 80 105 0 0 0 0 0 0 0 0 0 0
Totale 10.545